Neonatal desensitization for the study of regenerative medicine

Roberton, Victoria H., Rosser, Anne Elizabeth ORCID: https://orcid.org/0000-0002-4716-4753 and Kelly, Claire M. 2015. Neonatal desensitization for the study of regenerative medicine. Regenerative Medicine 10 (3) , pp. 265-274. 10.2217/rme.14.76

Full text not available from this repository.

Abstract

Cell replacement is a therapeutic option for numerous diseases of the CNS. Current research has identified a number of potential human donor cell types, for which preclinical testing through xenotransplantation in animal models is imperative. Immune modulation is necessary to promote donor cell survival for sufficient time to assess safety and efficacy. Neonatal desensitization can promote survival of human donor cells in adult rat hosts with little impact on the health of the host and for substantially longer than conventional methods, and has subsequently been applied in a range of studies with variable outcomes. Reviewing these findings may provide insight into the method and its potential for use in preclinical studies in regenerative medicine.

Item Type:	Article
Date Type:	Publication
Status:	Published
Schools:	Biosciences Medicine MRC Centre for Neuropsychiatric Genetics and Genomics (CNGG) Neuroscience and Mental Health Research Institute (NMHRI)
Subjects:	Q Science > QR Microbiology R Medicine > R Medicine (General)
Publisher:	Future Medicine
ISSN:	1746-0751
Last Modified:	28 Oct 2022 09:23
URI:	https://orca.cardiff.ac.uk/id/eprint/74371

Citation Data

Cited 3 times in Scopus. View in Scopus. Powered By Scopus® Data

Actions (repository staff only)

Edit Item